John R. Kasich, Governor Tracy J. Plouck, Director. Rick Massatti, PhD Brad DeCamp, MPA
|
|
|
- Benedict Nelson
- 8 years ago
- Views:
Transcription
1 John R. Kasich, Governor Tracy J. Plouck, Director Rick Massatti, PhD Brad DeCamp, MPA
2 Overdose episodes are increasing According to the EMS Reporting Incident System, the number of potentially drug-related overdoses more than doubled from 4,010 in 2003 to 11,954 in More and more clients coming into the publicallyfunded behavioral health treatment system are addicted to opiates. Primary diagnosis of opiate abuse and dependence rose from 5,790 in SFY 2001 to 24,833 in SFY
3 Increased opiate use has also led to the increased prevalence of neonatal abstinence syndrome (NAS) In 2013, there were 1,701 NAS inpatient / ER admissions according to the Ohio Hospital Association. 3
4 NAS inpatient hospitalization rate per 10,000 live births, Ohio, Rate per 10, Year Source: Ohio Hospital Association 4
5 As NAS cases became more prevalent, inflation-adjusted total inpatient costs associated with NAS increased. From $6.5 million in 2004 to $99.2 million in 2013 Inflation-adjusted total outpatient costs also grew From $59,339 in 2010 to $583,718 in
6 Average length of stay for inpatient settings, NAS infants vs. All infants, Ohio, Average LOS (days) NAS Infants All Infants Year Source: Ohio Hospital Association 6
7 7
8 8
9 9
10 10
11 11
12 Crisis Intervention Detoxification Medication Assisted Treatment Residential Financial Health Legal Food Assistance Educational Vocational 12
13 13
14 14
15 15
16 16
17 17
18 In August 2013, the Kasich Administration announced plans to address the epidemic. The Maternal Opiate Medical Support (M.O.M.S.) Project will improve health outcomes and reduce costs associated with extended hospital stays by neutralizing the impact of NAS. 18
19 $4.2 million program over three years Goal is to support interventions and prenatal treatments that improve outcomes for 300 women and babies Funds clinical (e.g., MAT) and non-clinical services (e.g., housing vouchers, transportation, brief babysitting) 19
20 20
21 MOMS Pilot Sites CompDrug, Inc. (Columbus) (614) First Step Home (Cincinnati) (513) Health Recovery Services (Athens) (740) MetroHealth (Cleveland) (216)
22 Preliminary data 63 women enrolled as of November 2014 that were in the first or second trimester 100% of women have received STD screening 82% of women adhered to MAT 18% of women tested positive for illicit opioids 22
23 The MOMS Project will have a web portal that serves as a resource for MOMS pilot sites and all health professionals in the state of Ohio. 23
24 The website will have links to decision trees that serve as guidelines for OB/GYN care and behavioral health practitioners. Resources will be available for: Screening NAS AOD Tobacco Depression Domestic Violence Prenatal Care Motivational interviewing MAT & pain mgmt. protocols Birth plan Person-centered care plan Other Community services Postnatal care Emergency Petition form Admission/Discharge forms 24
25 25
26 26
27 665 Physicians with DATA 2000 Waivers Challenges 21 Opiate Treatment Programs (OTPs) 15 Methadone 3 Buprenorphine only 3 VA programs Access varies by region 27
28 Program Name City Phone Sponsor First Name Sponsor Last Name Opiate Substitution Services, VAMC - Cincinnati Division Cincinnati (513) Show Lin Community Action Against Addiction Cleveland Gladys Hall Quest Recovery & Prevention Services Canton (330) Keith Hochadel Community Health Center Akron (330) Robert Stokes Project C.U.R.E., Inc. Dayton (937) Virgil McDaniel Meridian Community Care Youngstown (330) Lawerence Moliterno CompDrug Columbus (614) Dustin Mets Cleveland VA Medical Center-Wade Park Division, Opiod Treatment Program Cleveland P. Eric Konicki Bureau of Drug Abuse-Cleveland Treatment Center Cleveland (216) Leonard Collins Zepf Center Toledo (419) Marilyn Rule Central Community Health Board of Hamilton County, Drug Services Program Cincinnati (513) Bernard Young Department of Veteran Affairs Dayton (937) x2986 Richard Riddle Maryhaven Columbus (614) Grant Schroeder Premier Care of Ohio, INC Cincinnati (513) Daniel Brown Community Counseling and Treatment Services, Inc. Ironton (740) Paul Vernier Health Recovery Services, Inc. Jackson (740) Joe Gay Sunrise Treatment Center, LLC Cincinnati (513) Steven Smith Clermont Recovery Center, Inc. Batavia (513) Steven Goldsberry Premier Care of Ohio, INC Columbus (614) Daniel Brown University of Cincinnati Physicians Company, LLC (UCPC,LLC) Cincinnati (513) Melissa DelBello The Crossroads Medication Assisted Treatment Program Cincinnati (513) Jacqueline Butler Lutheran Hospital Alcohol and Drug Recovery Center Cleveland (216) Kris Bennett 28
29 A professional network dedicated to providing leadership in the provision of women s alcohol, tobacco and other drug rehabilitation programming. 29
30 Organization accomplishes its mission through: Developing and disseminating best practices for women s programs Improving identification and referral of substance abusing women by human services agencies Assuring women s access to clinically appropriate prevention and treatment Increasing awareness of women s substance abuse and effective treatment technologies 30
31 Project DAWN is a community-based overdose education and naloxone distribution program. Naloxone is an prescription opioid antagonist widely utilized by medical professionals. Ejects heroin and other opioids from receptors in the brain reversing the respiratory depression caused by an overdose. Has no pharmacological effect and has no potential for abuse (non-scheduled). Can be safely administered by intranasal, intravenous or intramuscular injection. Works rapidly (2-8 min.) and wears off in minutes. No effect if opioids are not present. 31
32 Project DAWN participants receive training on: Recognizing the signs and symptoms of overdose Distinguishing between different types of overdose Performing rescue breathing Calling emergency medical services Administering intranasal Naloxone 32
33 33
34 OhioMHAS Resources Toll-free helpline: (877) Addiction Service Providers (Link) Mental Health Providers (Link) MOMS Project (Link) Buprenorphine Protocol (Link) County Behavioral Health Authorities (Link) (614) Women s Network (Link) (513) Project DAWN (Link) 34
35 Substance Abuse and Mental Health Services Administration Resources TIP 40: Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction (Link) TIP 43: Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs (Link) TIP 51: Substance Abuse Treatment Addressing the Specific Needs of Women (Link) 35
36 Rick Massatti, PhD, MSW, MPH, LSW Health Services Policy Specialist Ohio Dept. of Mental Health & Addiction Services 30 East Broad Street, 8 th Floor Columbus, Ohio Phone (614) Rick.Massatti@mha.ohio.gov Brad DeCamp, MPA State Opioid Treatment Authority Ohio Dept. of Mental Health & Addiction Services 30 East Broad Street, 36 th Floor Columbus, Ohio Phone (614) Brad.Decamp@mha.ohio.gov 36
Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
John R. Kasich, Governor Orman Hall, Director
John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic
Allyse Adams PC, LICDC Oriana House, Inc.
Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In
HOPE Helping Opiate- Addicted Pregnant women Evolve
HOPE Helping Opiate- Addicted Pregnant women Evolve Medical Director: Michael P. Marcotte, MD TriHealth-Good Samaritan Hospital Cincinnati Ohio MHAS MOMs Grant 2014-2016 Ohio MHAS MOMs Grant 2014-2016
Medication Assisted Treatment
Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice
WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE
Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,
Testimony of The New York City Department of Health and Mental Hygiene. before the
Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
Mental Health and Addiction
Mental Health and Addiction Ohio s community mental health and addiction services system includes both Medicaid and non Medicaid services coordinated through local boards of alcohol and drug addiction
Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates
Substance Abuse During Pregnancy: Moms on Meds Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates 2010 National Survey on Drug Use and Health An estimated 4.4% of pregnant women reported
The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section
The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who
OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines
OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines Guideline Evaluation and Treatment Planning Discharge Planning Admission Criteria Continued Stay Criteria Discharge
Care Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
BREAKING THE CYCLE. Clermont County s 2015 Response to the Opiate Epidemic
BREAKING THE CYCLE Clermont County s 2015 Response to the Opiate Epidemic SPONSORED BY: Clermont County Mental Health & Recovery Board and Clermont County Public Health Understanding the Opiate Epidemic
Performance Standards
Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best
Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment
Testimony of Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of Health and Mental Hygiene before the New York City
P U B L I C H E A L T H A D V I S O R Y
The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619Tel: 617-624-6000 Fax: 617-624-5206 www.mass.gov/dph
Opioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.
New Jersey Substance Abuse Monitoring System The NJSAMS Report May 2011 Admissions to Substance Abuse Treatment in New Jersey eroin is a semi-synthetic opioid drug derived from morphine. It has a high
Testimony on Addressing Heroin and Opioid Addiction. Theodore Dallas. Secretary, Department of Human Services. Center for Rural Pennsylvania
Testimony on Addressing Heroin and Opioid Addiction Theodore Dallas Secretary, Department of Human Services Center for Rural Pennsylvania July 29, 2015 1 P a g e Introduction Good morning Senator Yaw,
Eugenia Cash LSW, MSSA, CDCA William M. Denihan Board Chair Chief Executive Officer SERVICES DIRECTORY Published July 2015
Eugenia Cash LSW, MSSA, CDCA Board Chair William M. Denihan Chief Executive Officer SERVICES DIRECTORY Published July 2015 EMERGENCY RESOURCES FOR ADULTS AND CHILDREN 24-HOUR ALCOHOL AND/OR OTHER DRUG
Presentation to the Boston HIV Planning Council. Lydie Ultimo, MSW Director Bureau of Substance Abuse Services
Presentation to the Boston HIV Planning Council Lydie Ultimo, MSW Director Bureau of Substance Abuse Services Responsibilities of the Bureau of Substance Abuse Services License addiction treatment programs
Magee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
Governor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu
Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina
NC Perinatal & Maternal Substance Abuse Initiative
NC Perinatal & Maternal Substance Abuse Initiative NC Division of MH/DD/SAS Community Policy Management Best Practice Team Starleen Scott Robbins, LCSW Illicit drug use among pregnant women in the U.S.
Collaborative Care for Pregnant Women with Substance Use Disorders
Collaborative Care for Pregnant Women with Substance Use Disorders Alane O Connor DNP Maine Dartmouth Family Medicine Residency MaineGeneral Medical Center Dartmouth Medical School Vanderbilt University
Opioid Use in Pregnancy: A Community s Approach, The Children and Recovering Mothers (CHARM) Collaborative
Opioid Use in Pregnancy: A Community s Approach, The Children and Recovering Mothers (CHARM) Collaborative Nancy K. Young, PhD Sally Borden, MEd Karen Shea, MSW Agenda Overview of the Issue Medication
Recovery Outcomes for Opiate Users. FRN Research Report November 2013
Recovery Outcomes for Opiate Users FRN Research Report November 2013 Introduction Opiate use in America is at epidemic levels. The latest surveys show 4.5 million Americans using prescription painkillers
Treatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
Ohio Legislative Service Commission
Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing
TREATMENT MODALITIES. May, 2013
TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.
Neonatal Abstinence Syndrome and Drug Use Among Pregnant Women in Ohio 2004-2011
Neonatal Abstinence Syndrome and Drug Use Among Pregnant Women in Ohio 2004-2011 Epidemiological Report, No. 1 November 2013 Prepared by: Ohio Department of Mental Health and Addiction Services Office
Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
Federal Response to Opioid Abuse Epidemic
Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government
MEDICALLY MONITORED ACUTE TREATMENT SERVICES. Brief Guide for Providers
MEDICALLY MONITORED ACUTE TREATMENT SERVICES Brief Guide for Providers Introduction: Pregnant women are a priority population for substance abuse treatment services. The Bureau of Substance Abuse Services
How To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
2013 OHIO DRUG OVERDOSE DATA: GENERAL FINDINGS 1
Number of Deaths Rate per 100,000 persons 2013 OHIO DRUG OVERDOSE DATA: GENERAL FINDINGS 1 Drug overdose deaths continue to be a public health crisis in Ohio with a 413 percent increase in the number of
CENTER FOR RURAL PA PUBLIC HEARING OPIATE ABUSE TREATMENT AND RECOVERY SERVICES. York, PA. August 18, 2015
CENTER FOR RURAL PA PUBLIC HEARING OPIATE ABUSE TREATMENT AND RECOVERY SERVICES York, PA August 18, 2015 Hello. My name is Jack Carroll, and I m the Executive Director of the Cumberland-Perry Drug and
Use of Pharmacotherapies by Substance Abuse Treatment Facilities
Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1
Acronyms for the Prevention and Treatment of Substance Use Disorders. Prepared by Mental Health Legal Advisors Committee November 2015
s for the Prevention and Treatment of Substance Use Disorders Prepared by Mental Health Legal Advisors Committee November 2015 Acro ABH ACA A- CRA ACC Association A statewide association ABH of Behavioral
Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
Addressing Substance Use in Pregnancy
Addressing Substance Use in Pregnancy Stefan Maxwell, MD Director, NICU, CAMC Women and Children s Hospital Chair, Drug Use in Pregnancy Committee West Virginia Perinatal Partnership July 31, 2013 WV Early
Various therapies are used in the
National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Overview of Opioid Treatment Programs within the United States: 2008 In Brief In 2008, a total of 1,132 (8 of all
The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community
The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community November 2014 INTRODUCTION The Heroin
Medication is not a part of treatment.
Medication is not a part of treatment. Medication can be an effective part of treatment. Medication is used in the treatment of many diseases, including addiction. Medical decisions must be made by trained
Addressing Substance Abuse in the Child Welfare Population: Lessons Learned in Vermont
Agency of Human Services Alcohol and Drug Abuse Programs Blueprint for Health Addressing Substance Abuse in the Child Welfare Population: Lessons Learned in Vermont Tri-Branch Institute on Child Social
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
VENTURA COUNTY ALCOHOL & DRUG PROGRAMS
VENTURA COUNTY ALCOHOL & DRUG PROGRAMS women s services Helping women recover (805) 981-9200 1911 Williams Drive, Oxnard, CA 93036 www.venturacountylimits.org recovery VCBH ALCOHOL & DRUG PROGRAMS WOMEN
Neonatal Abstinence Syndrome (NAS): A Preventable Crisis
Neonatal Abstinence Syndrome (NAS): A Preventable Crisis Sponsored by: www.ccatsober.org Neonatal Abstinence Syndrome (NAS): A Preventable Crisis Neonatal Abstinence Syndrome (NAS) A Preventable Crisis:
Introduction to Neonatal Abstinence Syndrome
Introduction to Neonatal Abstinence Syndrome Cara Christ, MD Director, Arizona Department of Health Services Learning Objectives 1.Define Neonatal Abstinence Syndrome 2.Describe Neonatal Abstinence Syndrome
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
EPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
Advances in MAT for Opioid Dependence: How Medication Can Help Drug Courts Reduce Recidivism and Improve Client Outcomes
Advances in MAT for Opioid Dependence: How Medication Can Help Drug Courts Reduce Recidivism and Improve Client Outcomes National Association of Drug Court Professionals June 10, 2009 Rhonda Myers, MA,
Beyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
Prescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
Substance Abuse Treatment Services Objective and Performance Measures
Report to The Vermont Legislature Substance Abuse Treatment Services Objective and Performance Measures In Accordance with Act 179 (2014) Sec. E.306.2 Submitted to: Submitted by: Prepared by: Joint Fiscal
Use of Vivitrol for Alcohol and Opioid Addiction
Use of Vivitrol for Alcohol and Opioid Addiction Ken Bachrach, Ph.D. Clinical Director, Tarzana Treatment Centers, Inc. kbachrach@tarzanatc.org What is Vivitrol? An injectable from of naltrexone, which
8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview
Who We Are BHG s Medical Mission BHG Company Overview Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. Our treatment centers provide pharmacotherapeutic maintenance
Strategic Plan for Alcohol and Drug Abuse
Strategic Plan for Alcohol and Drug Abuse Created: July 15, 2007 Updated: January 2, 2008 1 GARRETT COUNTY, MARYLAND STRATEGIC PLAN FOR ALCOHOL AND DRUG ABUSE Vision: Mission: A safe and drug free Garrett
Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014
Outcomes for Opiate Users at FRN Facilities FRN Research Report September 2014 Introduction The illicit use of opioids has reached epidemic proportions in the United States (Alford, 2007; Meges et al,
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule
Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data
Volume #1 October 2015 PUBLIC HEALTH ISSUE BRIEF Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data October 2015 Partners for a Healthier Community, Inc.
Structure and Function
Structure and Function OKLAHOMA State SSA Director Mr. Ben Brown, Deputy Commissioner Oklahoma Department of Mental Health and Substance Abuse Services P.O. Box 53277 Oklahoma City, OK 73152-3277 Phone:
Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner. NASADAD 2015 Annual Meeting
Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner NASADAD 2015 Annual Meeting Background Goal of Health Care Reform Triple Aim: Better Population
Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
National Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
Updated on Substance Abuse Treatment Centers in New Mexico
Updated on Substance Abuse Treatment Centers in New Mexico Update on Substance Abuse Treatment Centers in New Mexico Presentation to: The Legislative Health and Human Services Committee Wayne W. Lindstrom,
The National Community Detoxification Pilot
The National Community Detoxification Pilot Aoife Dermody, Progression Routes Initiative NDCI, 2011 Community Detoxification Protocols Guidelines for outpatient detoxification from methadone or benzodiazepines
Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course
The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,
DrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM
DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of
Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director
Heroin Overdose Trends and Treatment Options Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Type date here www.gatewayrehab.org Drug Overdose Deaths Increasing in Allegheny County Roberta Lojak holds
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?
Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears
Advances in Addiction Science and Treatment. Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014
Advances in Addiction Science and Treatment Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014 Treatment Research Research Institute, Institute, 20132012 Presentation 1. What is driving
Provider enews TREATING PRESCRIPTION DRUG ADDICTION
Provider enews TREATING PRESCRIPTION DRUG ADDICTION Treating addiction to prescription opioids July 2012 Several options are available for effectively treating prescription opioid addiction. These options
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
PRENATAL DRUG USE AND NEWBORN HEALTH. Federal Efforts Need Better Planning and Coordination
United States Government Accountability Office Report to Congressional Requesters February 2015 PRENATAL DRUG USE AND NEWBORN HEALTH Federal Efforts Need Better Planning and Coordination GAO-15-203 Highlights
Fairfax-Falls Church Community Services Board. 106-08-Alcohol and Drug Crisis Intervention and Assessment Services
106-08-Alcohol and Drug Crisis Intervention and Assessment Services Fund/Agency: 106 Fairfax-Falls Church Community Services Board Personnel Services $1,425,389 Operating Expenses $344,933 Recovered Costs
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP
Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition
Testimony on Opioid Overdose Prevention Daniel Raymond, Policy Director, Harm Reduction Coalition Presented on March 25, 2014 to the House Appropriations Subcommittee on Labor, Health and Human Services,
Rx and Heroin Abuse :Taking Action
Rx and Heroin Abuse :Taking Action Dan Hicks, Manager, Prevention Services November 21, 2014 Page 1 Rx Abuse & Heroin: Increasing Awareness Young people are abusing prescription drugs at alarming rates.
1. THE OPIOID EPIDEMIC IN WISCONSIN ISSUE BRIEF
Wisconsin Community Health Centers: Building Capacity to Combat Opiate Addiction ISSUE BRIEF 1. THE OPIOID EPIDEMIC IN WISCONSIN ommunities across the nation are grappling with the Cdevastating effects
From the street to the NICU. Richard Christensen, PA, CAS
From the street to the NICU Richard Christensen, PA, CAS Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a stand-alone
4. Program Regulations
MassHealth Substance Abuse Treatment Manual Subchapter Number and Title Table of Contents Transmittal Letter SAT-15 Page iv Date 07/01/06 4. Program Regulations 418.401: Introduction... 4-1 418.402: Definitions...
COMMUNITY MENTAL HEALTH RESOURCES
COMMUNITY MENTAL HEALTH RESOURCES (Adult Mental Health Initiative) Ramsey & Washington Information gathered by: MN. State Advisory Council on Mental Health 17-25 Year Old Committee Mental Health Services
Medication Assisted Treatment: Program Implementation & Outcomes Cara Renzelli, PhD Richard Foster, PhD
Medication Assisted Treatment: Program Implementation & Outcomes Cara Renzelli, PhD Richard Foster, PhD Type date here 800-472-1177 www.gatewayrehab.org Gateway Rehab is a private, not-for-profit organization
One example: Chapman and Huygens, 1988, British Journal of Addiction
This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman
Objectives. Background
Development and Implementation of a Pharmacist-Managed Intranasal Naloxone Distribution Program in a Veterans Affairs Healthcare Facility and Associated Community Clinics Innovative Practices Award Finalist
Medication-Assisted Treatment for Opioid Addiction
Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid
In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.
Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.
Opiate Abuse and Mental Illness
visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?